Tobacco carcinogen NNK promotes pancreatic cancer proliferation via LINC00857/β-catenin

  • 0Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

|

|

Summary

This summary is machine-generated.

Nicotine-derived nitrosamine ketone (NNK) from tobacco smoke promotes pancreatic cancer (PC) growth by upregulating LINC00857 and the β-catenin pathway. Smoking cessation is crucial for PC prevention.

Area Of Science

  • Oncology
  • Molecular Biology
  • Cancer Research

Background

  • Smoking is a significant risk factor for pancreatic cancer (PC).
  • Nicotine-derived nitrosamine ketone (NNK), a tobacco carcinogen, is implicated in cancer promotion, but its role in PC progression and regulation of long non-coding RNAs (lncRNAs) like LINC00857 is not fully understood.

Purpose Of The Study

  • To investigate the role of NNK in driving PC growth.
  • To elucidate the underlying molecular mechanisms, focusing on the regulation of LINC00857 and its potential downstream targets.

Main Methods

  • Human PC cell lines (CFPAC-1, Panc-1) were treated with NNK.
  • Cell proliferation was assessed using CCK-8, colony formation, and EdU assays.
  • LINC00857 expression was analyzed via bioinformatic interrogation of public and institutional databases.
  • LINC00857 knockdown was performed using siRNA.
  • β-catenin expression was measured by Western blotting and qRT-PCR.

Main Results

  • NNK exposure enhanced PC cell proliferation.
  • LINC00857 was found to be upregulated in PC and correlated with smoking status.
  • Knockdown of LINC00857 inhibited PC cell proliferation.
  • NNK-induced upregulation of β-catenin was suppressed by LINC00857 knockdown at both protein and transcriptional levels.

Conclusions

  • NNK may promote PC progression via the LINC00857/β-catenin signaling axis.
  • These findings underscore the importance of smoking cessation in PC prevention strategies.

Related Concept Videos

Canonical Wnt Signaling Pathway 02:54

8.6K

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...

mTOR Signaling and Cancer Progression 03:03

3.6K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Non-Canonical Wnt Signaling Pathways 01:41

7.2K

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...

Tumor Progression 02:07

6.1K

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

lncRNA - Long Non-coding RNAs 02:39

8.4K

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Mutagenicity and Carcinogenicity 01:25

1.1K

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...